Sales and Marketing

Showing 15 posts of 11528 posts found.

Takeda financials show why the Shire deal was needed

May 14, 2018 Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …

Pharma unfazed by Trump price-reduction proposals

May 14, 2018 Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical

President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …

FDA awards first paediatric MS approval to Novartis’ Gilenya

May 14, 2018 Sales and Marketing FDA, gilenya, multiple sclerosis, pharma

The FDA has awarded approval for what it says is its first drug for the treatment of multiple sclerosis (MS) …

Akari CEO resigns over allegations of spending company funds

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …

Janssen’s Tremfya gets go-ahead from NICE in plaque psoriasis

May 11, 2018 Medical Communications, Sales and Marketing Janssen, NICE, Tremfya, UK, pharma, psoriasis

NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the …

Top Ten most popular articles on Pharmafile.com this week

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical

It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …

C4 Therapeutics fills out C-Suite with CEO appointment

May 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical

C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …

Lilly moves quickly to secure $1.6bn buyout of Armo

May 10, 2018 Medical Communications, Sales and Marketing Armo Biosciences, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …

NanoBots: The science of small to dwarf the disease

May 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Precision Medicine, nanorobots, pharma

Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …

FDA launches lawsuits against stem cell clinics after patients rendered blind

May 10, 2018 Medical Communications, Sales and Marketing FDA, Stem cells, US, macular degeneration, pharma

At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem …

Lodo and Roche go digging for drug candidates, after $1bn deal

May 10, 2018 Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken …

The new and improved Spring 2018 edition of Pharmafile is available to read online now!

May 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CNS, Cancer, Pharmafocus, cardiovascular, cvd, oncology, pharmafile

The Spring 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

BenevolentAI names former UK Minister as new Group CEO

May 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, BenevolentAI, Facebook, UK, appointment, google

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …

European approval for tablet formulation of Lynparza in ovarian cancer

May 8, 2018 Research and Development, Sales and Marketing AstraZeneca, Cancer, EMA, Europe, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s poly ADP-ribose polymerase (PARP) inhibitor Lynparza (olaparib) has been approved for use in Europe, it has emerged, …
The Gateway to Local Adoption Series

Latest content